Skip to main content

Thank you for visiting You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Rent or buy this article

Prices vary by article type



Prices may be subject to local taxes which are calculated during checkout


  1. Schaefer, K.A. et al. Nat. Methods 14, 547–548 (2017).

    Article  CAS  Google Scholar 

  2. Jiang, F. & Doudna, J.A. Annu. Rev. Biophys. 46, 505–529 (2017).

    Article  CAS  Google Scholar 

  3. Li, D. et al. Nat. Biotech. 31, 681–683 (2013).

    Article  CAS  Google Scholar 

  4. Hwang, W.Y. et al. PLoS ONE 8, e68708 (2013).

    Article  CAS  Google Scholar 

  5. Uchimura, A. et al. Genome Res. 25, 1125–1134 (2015).

    Article  CAS  Google Scholar 

  6. Mianne, J. et al. Genome Med. 8, 16 (2016).

    Article  Google Scholar 

  7. Iyer, V. et al. Nat. Methods 12, 479 (2015).

    Article  CAS  Google Scholar 

  8. Nakajima, K. et al. Sci. Rep. 6, 34703 (2016).

    Article  CAS  Google Scholar 

  9. Anonymous. Nat. Methods 14, 541 (2017).

Download references


The authors are funded to produce mouse models using Cas9 as part of the International Mouse Phenotyping Consortium from Genome Canada and Ontario Genomics OGI-051 (L.M.J.N.), the National Human Genome Research Institute, the NIH Common Fund, through the Office of Strategic Coordination/Office of the NIH Director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Cancer Institute, National Institute of Neurological Disorders and Stroke, National Institute on Deafness and Other Communication Disorders, National Institute of Environmental Health Sciences, National Institute of Drug Abuse and the Office of Research on Women's Health awards UM1HG006348 (J.D.H., J.R.S., L.T., S.D.M.B.), UM1OD023321 (L.M.J.N., K.C.L.) and UM1OD023222 (S.D.M.) and MRC IMPC Strategic Award 53658 (L.T., S.D.M.B.).

Author information

Authors and Affiliations


Corresponding author

Correspondence to Lauryl M J Nutter.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and Permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Nutter, L., Heaney, J., Lloyd, K. et al. Response to “Unexpected mutations after CRISPR–Cas9 editing in vivo”. Nat Methods 15, 235–236 (2018).

Download citation

  • Published:

  • Issue Date:

  • DOI:

This article is cited by


Quick links

Nature Briefing: Translational Research

Sign up for the Nature Briefing: Translational Research newsletter — top stories in biotechnology, drug discovery and pharma.

Get what matters in translational research, free to your inbox weekly. Sign up for Nature Briefing: Translational Research